The Law Offices of Frank R. Cruz announces an investigation of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) on behalf of investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON ZIMMER BIOMET HOLDINGS, INC. (ZBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.

What Is The Investigation About?

On November 5, 2025, Zimmer released its third quarter 2025 financial results, reporting net sales of about $2 billion, due to “weakness in Latin America, Emerging Markets in Europe and non-core businesses.” The Company also reduced the top end of its full-year organic revenue growth forecast from 4.5% to 4.0%, due, in part, to “continued weakness in restorative therapies,” and “the modest slowdown in the U.S. revision market for both hips and knees persisting throughout the rest of 2025.”

On this news, Zimmer’s stock price fell $15.63, or 15.2%, to close at $87.55 per share on November 5, 2025, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased Zimmer securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

The Law Offices of Frank R. Cruz,

2121 Avenue of the Stars, Suite 800,

Century City, California 90067

Call us at: 310-914-5007

Email us at: info@frankcruzlaw.com

Visit our website at: www.frankcruzlaw.com.

Follow us for updates on Twitter at twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251112451558/en/